Clinical Trial Update: Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing cannabidiol-assisted learning for Generalized Anxiety Disorder is currently recruiting, sponsored by Wayne State University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Wayne State University | Conditions: Generalized Anxiety Disorder (GAD), Anxiety Disorders | Phase 3 | Status: RECRUITING